File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Usefulness of Lactate-Free Asian Pacific Association for the Study of Liver Acute-on-Chronic Liver Failure (ACLF) Research Consortium (AARC)-ACLF score for predicting short-term mortality in patients with alcoholic liver disease

TitleUsefulness of Lactate-Free Asian Pacific Association for the Study of Liver Acute-on-Chronic Liver Failure (ACLF) Research Consortium (AARC)-ACLF score for predicting short-term mortality in patients with alcoholic liver disease
Authors
Issue Date2018
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/
Citation
The Liver Meeting 2018, American Association for the Study of Liver Diseases (AASLD), San Francisco, USA, 9-13 November 2018. Abstracts in Hepatology, 2018, v. 68 n. Suppl. 1, p. 794A-795A How to Cite?
AbstractBackground: Asian Pacific Association for the Study of Liver (APASL) acute-on-chronic liver failure (ACLF) Research Consortium (AARC) proposed new prognostic scoring system of ACLF including lactate. However, lactate is not routinely checked in clinical practice of patient with ACLF in Korea. Therefore, we aimed to investigate the predictive accuracy of lactate-free AARC-ACLF score for predicting short-term mortality in patients with alcoholic liver disease Methods: A total of 749 ALD patients who had liver failure (bilirubin≥5mg/dL and INR≥1.5) in AARC database were investigated. Diagnostic performances for short-term mortality were compared according to the area under receiver operating characteristic (AUROC) curve. Predictive accuracy of lactate-free AARCACLF score were compared with other prognostic scores in 143 ALD patients with liver failure and 65 ALD patients with ACLF according to AARC definition in Korean ACLF cohort. Results: Among 749 patients, 28-day and 90-day mortality were 40.3% and 51.5%. There were no significant differences in AUROC for predicting 28-day and 90-day mortality between AARC-ACLF score and lactate-free AARC-ACLF score (28-day mortality: 0.758 vs. 0.759, P=0.938, 90-day mortality: 0.747 vs. 0.740, P=0.383). In Korean ACLF cohort, the AUROCs of lactate-free AARC-ACLF score for predicting 28-day and 90-day mortality were 0.861 and 0.846 in ALD with liver failure, and 0.865 and 0.873 in ALD patients with ACLF according to AARC definition, respectively. In Korean ALD patients with liver failure and ACLF according to AARC definition, diagnostic performance of lactate-free AARCACLF score for predicting 28-day and 90-day mortality was comparable to those of Model for End-stage Liver Disease (MELD), MELD-Na, Chronic Liver Failure-Sequential Organ Failure Assessment score Conclusion: Lactate-free AARCACLF score is as excellent as AARC-ACLF score in predicting short-term mortality in ALD patients with liver failure of AARC database and Korean ACLF cohort
DescriptionPoster Presentation - no. 1384
Persistent Identifierhttp://hdl.handle.net/10722/275339
ISSN
2017 Impact Factor: 14.079
2015 SCImago Journal Rankings: 4.752

 

DC FieldValueLanguage
dc.contributor.authorSong, DS-
dc.contributor.authorKim, TY-
dc.contributor.authorKim, HY-
dc.contributor.authorYoon, E-
dc.contributor.authorKim, DJ-
dc.contributor.authorJia, J-
dc.contributor.authorChoudhury, AK-
dc.contributor.authorMahtab, MA-
dc.contributor.authorDevarbhavi, H-
dc.contributor.authorDuan, Z-
dc.contributor.authorChen, Y-
dc.contributor.authorEapen, CE-
dc.contributor.authorGoel, A-
dc.contributor.authorNing, Q-
dc.contributor.authorMa, K-
dc.contributor.authorChawla, YK-
dc.contributor.authorDhiman, RK-
dc.contributor.authorDuseja, AK-
dc.contributor.authorTaneja, S-
dc.contributor.authorHamid, SS-
dc.contributor.authorButt, AS-
dc.contributor.authorJafri, SMW-
dc.contributor.authorTan, SS-
dc.contributor.authorGhazinian, H-
dc.contributor.authorAmarapurkar, DN-
dc.contributor.authorTreeprasertsuk, S-
dc.contributor.authorLee, GH-
dc.contributor.authorLim, SG-
dc.contributor.authorHu, J-
dc.contributor.authorLesmana, LA-
dc.contributor.authorLesmana, CR-
dc.contributor.authorShukla, A-
dc.contributor.authorShah, S-
dc.contributor.authorKalal, CR-
dc.contributor.authorSahu, M-
dc.contributor.authorAbbas, Z-
dc.contributor.authorSollano, JD-
dc.contributor.authorCarpio, G-
dc.contributor.authorKarim, F-
dc.contributor.authorLau, GKK-
dc.contributor.authorRao, PN-
dc.contributor.authorPayawal, DA-
dc.contributor.authorDokmeci, A-
dc.contributor.authorYuen, RMF-
dc.contributor.authorPrasad, VGM-
dc.contributor.authorYokosuka, O-
dc.contributor.authorShrestha, A-
dc.contributor.authorJain, P-
dc.contributor.authorPaulson, I-
dc.contributor.authorSarin, SK-
dc.date.accessioned2019-09-10T02:40:35Z-
dc.date.available2019-09-10T02:40:35Z-
dc.date.issued2018-
dc.identifier.citationThe Liver Meeting 2018, American Association for the Study of Liver Diseases (AASLD), San Francisco, USA, 9-13 November 2018. Abstracts in Hepatology, 2018, v. 68 n. Suppl. 1, p. 794A-795A-
dc.identifier.issn0270-9139-
dc.identifier.urihttp://hdl.handle.net/10722/275339-
dc.descriptionPoster Presentation - no. 1384-
dc.description.abstractBackground: Asian Pacific Association for the Study of Liver (APASL) acute-on-chronic liver failure (ACLF) Research Consortium (AARC) proposed new prognostic scoring system of ACLF including lactate. However, lactate is not routinely checked in clinical practice of patient with ACLF in Korea. Therefore, we aimed to investigate the predictive accuracy of lactate-free AARC-ACLF score for predicting short-term mortality in patients with alcoholic liver disease Methods: A total of 749 ALD patients who had liver failure (bilirubin≥5mg/dL and INR≥1.5) in AARC database were investigated. Diagnostic performances for short-term mortality were compared according to the area under receiver operating characteristic (AUROC) curve. Predictive accuracy of lactate-free AARCACLF score were compared with other prognostic scores in 143 ALD patients with liver failure and 65 ALD patients with ACLF according to AARC definition in Korean ACLF cohort. Results: Among 749 patients, 28-day and 90-day mortality were 40.3% and 51.5%. There were no significant differences in AUROC for predicting 28-day and 90-day mortality between AARC-ACLF score and lactate-free AARC-ACLF score (28-day mortality: 0.758 vs. 0.759, P=0.938, 90-day mortality: 0.747 vs. 0.740, P=0.383). In Korean ACLF cohort, the AUROCs of lactate-free AARC-ACLF score for predicting 28-day and 90-day mortality were 0.861 and 0.846 in ALD with liver failure, and 0.865 and 0.873 in ALD patients with ACLF according to AARC definition, respectively. In Korean ALD patients with liver failure and ACLF according to AARC definition, diagnostic performance of lactate-free AARCACLF score for predicting 28-day and 90-day mortality was comparable to those of Model for End-stage Liver Disease (MELD), MELD-Na, Chronic Liver Failure-Sequential Organ Failure Assessment score Conclusion: Lactate-free AARCACLF score is as excellent as AARC-ACLF score in predicting short-term mortality in ALD patients with liver failure of AARC database and Korean ACLF cohort-
dc.languageeng-
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/-
dc.relation.ispartofHepatology-
dc.relation.ispartofAmerican Association for the Study of Liver Diseases (AASLD): The Liver Meeting 2018-
dc.titleUsefulness of Lactate-Free Asian Pacific Association for the Study of Liver Acute-on-Chronic Liver Failure (ACLF) Research Consortium (AARC)-ACLF score for predicting short-term mortality in patients with alcoholic liver disease-
dc.typeConference_Paper-
dc.identifier.emailYuen, RMF: mfyuen@hku.hk-
dc.identifier.authorityYuen, RMF=rp00479-
dc.identifier.hkuros304644-
dc.identifier.volume68-
dc.identifier.issueSuppl. 1-
dc.identifier.spage794A-
dc.identifier.epage795A-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats